NCT07432997 — "Pharmacological Enhancement of Glymphatic Function in Humans" trial site landscape

Public-registry site landscape for NCT07432997, “Pharmacological Enhancement of Glymphatic Function in Humans”, a Alzheimer Disease study sponsored by Applied Cognition. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07432997 (registry record)
Study title	Pharmacological Enhancement of Glymphatic Function in Humans
Official title	The Effect of Dexmedetomidine on Glymphatic Function in the Human Brain
Sponsor	Applied Cognition
Condition(s)	Alzheimer Disease
Phase	PHASE1 / PHASE2
Listed sites	2
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT07432997.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07432997 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Alzheimer Disease trials

← Eichor home · All tracked trials · Alzheimer Disease studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →